An Open Label Dose Escalation Trial of CA-4948 in Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome

This website uses cookies to improve your browsing experience and analyze site traffic. By using our site, you consent to our use of cookies, in accordance with our privacy policies. I Understand